Molecular characteristics and chromatin texture features in acute promyelocytic leukemia.

Mariana R B De Mello, Dulcineia M Albuquerque, Fernanda Gonçalves Pereira-Cunha, Krizzia B Albanez, Katia B B Pagnano, Fernando F Costa, Konradin Metze, Irene Lorand-Metze
Author Information
  1. Mariana R B De Mello: State University of Campinas, Campinas, Brazil.

Abstract

BACKGROUND: Acute promyelocytic leukemia is a cytogenetically well defined entity. Nevertheless, some features observed at diagnosis are related to a worse outcome of the patients.
METHODS: In a prospective study, we analyzed peripheral (PB) leukocyte count, immunophenotype, methylation status of CDKN2B, CDKN2A and TP73; FLT3 and NPM1 mutations besides nuclear chromatin texture characteristics of the leukemic cells. We also examined the relation of these features with patient's outcome.
RESULTS: Among 19 cases, 4 had a microgranular morphology, 7 presented PB leukocytes >10x109/l, 2 had FLT3-ITD and 3 had FLT3-TKD (all three presenting a methylated CDKN2B). NPM1 mutation was not observed. PB leukocyte count showed an inverse relation with standard deviation of gray levels, contrast, cluster prominence, and chromatin fractal dimension (FD). Cases with FLT3-ITD presented a microgranular morphology, PB leukocytosis and expression of HLA-DR, CD34 and CD11b. Concerning nuclear chromatin texture variables, these cases had a lower entropy, contrast, cluster prominence and FD, but higher local homogeneity, and R245, in keeping with more homogeneously distributed chromatin. In the univariate Cox analysis, a higher leukocyte count, FLT3-ITD mutation, microgranular morphology, methylation of CDKN2B, besides a higher local homogeneity of nuclear chromatin, a lower chromatin entropy and FD were associated to a worse outcome. All these features lost significance when the cases were stratified for FLT3-ITD mutation. Methylation status of CDNK2A and TP73 showed no relation to patient's survival.
CONCLUSION: in APL, patients with FLT3-ITD mutation show different clinical characteristics and have blasts with a more homogeneous chromatin texture. Texture analysis demonstrated that FLTD-ITD was accompanied not only by different cytoplasmic features, but also by a change in chromatin structure in routine cytologic preparations. Yet we were not able to detect chromatin changes by nuclear texture analysis of patients with the FTLD-TKD or methylation of specific genes.

References

  1. Diagn Pathol. 2011 Mar 30;6 Suppl 1:S9 [PMID: 21489204]
  2. J Biomol Screen. 2012 Jan;17(1):2-17 [PMID: 21965114]
  3. Blood. 2000 Mar 15;95(6):1942-9 [PMID: 10706859]
  4. Pathology. 2010;42(6):609-10; author reply 610-1 [PMID: 20854091]
  5. Nouv Rev Fr Hematol. 1991;33(1):1-4 [PMID: 1945818]
  6. BMC Cancer. 2010 Jun 05;10:260 [PMID: 20525386]
  7. Diagn Pathol. 2011 Jun 04;6:48 [PMID: 21639921]
  8. Leukemia. 2005 Jul;19(7):1153-60 [PMID: 15889156]
  9. Best Pract Res Clin Haematol. 2010 Dec;23(4):463-8 [PMID: 21130408]
  10. Cell Oncol. 2009;31(6):503-4 [PMID: 19940366]
  11. Epigenomics. 2010 Oct;2(5):601-4 [PMID: 22122044]
  12. Blood Rev. 2006 Jan;20(1):1-13 [PMID: 16426940]
  13. Ann Hematol. 1995 Dec;71(6):275-9 [PMID: 8534758]
  14. Anal Cell Pathol. 1993 Jul;5(4):203-12 [PMID: 8363982]
  15. Leuk Res. 2010 Jul;34(7):831-6 [PMID: 20096459]
  16. Clin Cancer Res. 2002 Jun;8(6):1897-903 [PMID: 12060634]
  17. Cancer Cell. 2010 Jan 19;17(1):13-27 [PMID: 20060365]
  18. Anal Quant Cytol Histol. 2008 Apr;30(2):92-8 [PMID: 18561745]
  19. Cytometry. 1998 May 1;32(1):51-6 [PMID: 9581624]
  20. Acta Haematol. 1993;89(2):110-2 [PMID: 8503243]
  21. Cell Oncol. 2006;28(1-2):55-9 [PMID: 16675881]
  22. PLoS One. 2010 Aug 16;5(8):e12197 [PMID: 20808941]
  23. Anal Quant Cytol Histol. 2008 Jun;30(3):175-84 [PMID: 18630843]
  24. Leukemia. 2006 Jan;20(1):103-14 [PMID: 16270043]
  25. Nat Biotechnol. 2011 Nov 20;29(12):1109-13 [PMID: 22101486]
  26. Hum Mol Genet. 2005 Apr 15;14 Spec No 1:R65-76 [PMID: 15809275]
  27. Diagn Pathol. 2011 Nov 03;6:107 [PMID: 22053830]
  28. Haematologica. 2010 May;95(5):745-51 [PMID: 20133893]
  29. Diagn Pathol. 2010 Jan 22;5:7 [PMID: 20148100]
  30. Haematologica. 2007 Oct;92(10):1431-2 [PMID: 18024380]
  31. Blood. 2009 Feb 26;113(9):1875-91 [PMID: 18812465]
  32. PLoS One. 2011;6(6):e20706 [PMID: 21698234]
  33. World J Surg. 2008 Dec;32(12):2744-6 [PMID: 18787892]
  34. Diagn Pathol. 2011 Sep 29;6:93 [PMID: 21958512]
  35. Hematology Am Soc Hematol Educ Program. 2006;:156-61, 514 [PMID: 17124055]
  36. Ann Hematol. 2010 Feb;89(2):225-8 [PMID: 19921191]
  37. Neoplasma. 2006;53(2):155-60 [PMID: 16575472]
  38. FASEB J. 1999 Jan;13(1):89-93 [PMID: 9872933]
  39. Blood Rev. 2003 Jun;17(2):71-97 [PMID: 12642121]
  40. Leuk Lymphoma. 2008 Dec;49(12):2387-9 [PMID: 19052993]
  41. Br J Haematol. 2003 Aug;122(4):571-8 [PMID: 12899712]
  42. Cytometry A. 2010 Dec;77(12):1101-2 [PMID: 20972968]
  43. Br J Haematol. 2004 May;125(4):463-9 [PMID: 15142116]
  44. Cell Oncol. 2006;28(5-6):331-3 [PMID: 17167186]
  45. Haematologica. 2011 Jan;96(1):174-6 [PMID: 20884714]

MeSH Term

Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
Chromatin
Chromatin Assembly and Disassembly
Cyclin-Dependent Kinase Inhibitor p15
Cyclin-Dependent Kinase Inhibitor p16
DNA Methylation
DNA Mutational Analysis
DNA-Binding Proteins
Female
Fractals
Humans
Immunophenotyping
Leukemia, Promyelocytic, Acute
Leukocyte Count
Male
Middle Aged
Mutation
Nuclear Proteins
Nucleophosmin
Predictive Value of Tests
Prognosis
Proportional Hazards Models
Prospective Studies
Tumor Protein p73
Tumor Suppressor Proteins
Young Adult
fms-Like Tyrosine Kinase 3

Chemicals

Biomarkers, Tumor
CDKN2B protein, human
Chromatin
Cyclin-Dependent Kinase Inhibitor p15
Cyclin-Dependent Kinase Inhibitor p16
DNA-Binding Proteins
NPM1 protein, human
Nuclear Proteins
TP73 protein, human
Tumor Protein p73
Tumor Suppressor Proteins
Nucleophosmin
FLT3 protein, human
fms-Like Tyrosine Kinase 3

Word Cloud

Created with Highcharts 10.0.0chromatinfeaturestextureFLT3-ITDPBnuclearmutationoutcomepatientsleukocytecountmethylationCDKN2BcharacteristicsrelationcasesmicrogranularmorphologyFDhigheranalysispromyelocyticleukemiaobservedworsestatusTP73NPM1besidesalsopatient'spresentedshowedcontrastclusterprominencelowerentropylocalhomogeneitydifferentBACKGROUND:AcutecytogeneticallywelldefinedentityNeverthelessdiagnosisrelatedMETHODS:prospectivestudyanalyzedperipheralimmunophenotypeCDKN2AFLT3mutationsleukemiccellsexaminedRESULTS:Among1947leukocytes>10x109/l23FLT3-TKDthreepresentingmethylatedinversestandarddeviationgraylevelsfractaldimensionCasesleukocytosisexpressionHLA-DRCD34CD11bConcerningvariablesR245keepinghomogeneouslydistributedunivariateCoxassociatedlostsignificancestratifiedMethylationCDNK2AsurvivalCONCLUSION:APLshowclinicalblastshomogeneousTexturedemonstratedFLTD-ITDaccompaniedcytoplasmicchangestructureroutinecytologicpreparationsYetabledetectchangesFTLD-TKDspecificgenesMolecularacute

Similar Articles

Cited By